Additionally, direct comparisons between CIRP and established biomarkers, such as C-reactive protein, IL-6, and TNF-α, should be conducted to assess their predictive value, sensitivity, and specificity for stroke outcomes. This evidence concerns the gene TNF and stroke disorder.